Does a panel of serum-derived exosomal miRNAs serve as a diagnostic biomarker for cardiovascular risk assessed by carotid intima-media thickness in patients with type 2 diabetes?
A panel of serum-derived exosomal miRNAs shows promise as a diagnostic biomarker for carotid atherosclerosis in patients with type 2 diabetes.
The identified miRNA panel represents a promising diagnostic biomarker for CAS in patients with T2DM, providing a foundation for the development of targeted therapies to address diabetic cardiovascular complications.
Wen Lu (Thu,) studied this question.